Cargando…
JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology
[Image: see text] c-Jun N-terminal kinase 3 (JNK3) is suggested to play a key role in neurodegenerative disorders, especially in Alzheimer’s disease (AD). However, it remains unclear whether JNK or amyloid β (Aβ) appears first in the disease onset. Postmortem brain tissues from four dementia subtype...
Autores principales: | Solas, Maite, Vela, Silvia, Smerdou, Cristian, Martisova, Eva, Martínez-Valbuena, Iván, Luquin, María-Rosario, Ramírez, María J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119940/ https://www.ncbi.nlm.nih.gov/pubmed/36976903 http://dx.doi.org/10.1021/acschemneuro.3c00093 |
Ejemplares similares
-
JNK3 Overexpression
in the Entorhinal Cortex Impacts
on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding
por: Ardanaz, Carlos G., et al.
Publicado: (2023) -
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016) -
A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
por: Aksman, Leon M, et al.
Publicado: (2023) -
The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019) -
Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer’s Disease Associated with Down Syndrome
por: Ichimata, Shojiro, et al.
Publicado: (2023)